News

Sylvester's sarcoma team, including, from right, Jonathan Trent, M.D., Ph.D., patient Ron Agypt, and Breelyn Wilky, M.D.

Sylvester Named GIST Center of Excellence by The Life Raft Group

Sarcoma specialist Jonathan Trent, M.D., Ph.D., and his team, including Breelyn Wilky, M.D., received the first GIST Center of Excellence award on behalf of Sylvester Comprehensive Cancer Center from The Life Raft Group on July 14 during Life Fest 2018, a weekend conference for patients, caregivers and medical experts.

Read more about the GIST award »

Miami sunset.

Can Cities Keep Their Cool?

Laurence S. Kalkstein, Ph.D., a bioclimatologist and voluntary faculty member with the Miller School of Medicine’s Department of Public Health Sciences, has spent the past 30 years studying the impact of weather on human health. He’s the director of the Synoptic Climatology Laboratory, whose research explores a vast array of meteorologic and environmental factors on plants, animals, people and disease.

Read more about the Synoptic Climatology Lab »

Researchers compared disparities in cancer risk and mortality among diverse populations in New York with those found in Florida in earlier studies. Video & Photo Gallery

Distinct Racial and Ethnic Differences in Cancer Mortality Revealed in Published Study

Expanding on previous work highlighting disparities in cancer risk and mortality among diverse populations in Florida, a research team from Sylvester Comprehensive Cancer Center analyzed almost 250,000 people who died from cancer between 2008 and 2014 in another state with a diverse population: New York. Results of this new study were published on July 19 in the journal Cancer Epidemiology, Biomarkers & Prevention.

Read more about the research findings »

Camillo Ricordi, M.D.

New Study Explores Effects of Omega-3 Fatty Acids and Vitamin D in Type 1 Diabetes

Scientists from the Diabetes Research Institute are launching a new clinical trial that will assess the impact of high-dose omega-3 fatty acids and vitamin D supplementation on halting the progression of type 1 diabetes. The study will compare the effects of the proposed intervention in children and adults newly diagnosed and in those with longer-standing type 1 diabetes to evaluate any benefit of early and late interventions.

Read more about the clinical trial »

From left, State Senator Oscar Braynon, Henri R. Ford, M.D., M.H.A., Joy Fishman, U.S. Senator Bill Nelson, Edward Abraham, M.D., and Hansel Tookes, M.D., M.P.H.

Senator Bill Nelson Tours Miller School’s Needle Exchange, Sees Opioid Epidemic First Hand

University of Miami champion U.S. Senator Bill Nelson toured the Miller School of Medicine’s needle exchange program on July 6. Joined by Edward Abraham, M.D., executive vice president for health affairs and CEO of UHealth – the University of Miami Health System, and Henri R. Ford, M.D., M.H.A., dean of the Miller School, Nelson got an in-depth look at the site’s comprehensive operations, including its mobile van.

Read more about Senator Nelson's visit »

News Archives

Office of the Dean

A message from the dean

Physician News

Read Med News

e-Update

Read e-Update